Get In Touch

Global Orphan Diseases Testing Market: Overview

Development of molecular biology has transformed the diagnosis and treatment of diseases. Modern test methods, which are based on the detection of DNA and RNA, offer several advantages over traditional methods in the detection of diseases. The new procedures can detect viruses, bacteria, and genetic variations more accurately and rapidly. The continuous innovation in technology is useful to personalize health care and offer better treatment plans to patients. Genetic sequencing provides various types of technologies for the diagnosis of genetic disorders, some of the prominent technologies being RT-PCR, microarray sequencing, and next-generation sequencing.

Availability of a wide range of molecular biology technologies for the diagnosis of diseases presents several choices depending on the cost of the test, capability of the testing method, and other parameters. These techniques are used for the diagnosis and testing of orphan diseases, also known as rare diseases. According to the criteria employed in the U.S., orphan diseases are rare diseases that affect less than 200,000 individuals in a population. According to the criteria applied in Europe, orphan diseases are rare diseases that affect less than five individuals among 10,000 people. At present, almost 5% of the world’s population is living with orphan diseases. According to various surveys, it is estimated that almost 75% of orphan diseases affect children and 30% of these patients die before attaining the age of five years. 80% of the orphan diseases are genetic in nature. Some of the orphan diseases are life-threatening. Approximately 700 orphan or rare diseases have been identified. Examples of orphan diseases include cystic fibrosis, Lou Gehrig's disease, and Tourette's syndrome. The diagnosis is generally carried out by genetic screening.

Global Orphan Diseases Testing Market: Drivers and Restraints

Increasing technological advancements in genomics for the diagnosis and treatment of rare diseases and availability of patient-specific therapies for these diseases are estimated to fuel the global orphan diseases testing market during the forecast period. Moreover, increase in genetic screening for the diagnosis of hereditary disorders is likely to augment the Orphan Diseases Testing Market from 2017 to 2025. Emergence of new detection technologies in the genomics has enhanced the diagnosis of orphan diseases. Manufacturers are focusing on development of techniques such as PCR, imaging, and microarrays with greater depth of interaction (DoI). The need for new detection technologies in the testing of orphan diseases is due to ineffective methods of screening, which often give false-positive and false-negative results. Therefore, there is a need in achieving effective screening of the disease, which can be filled with innovative approaches that are more effective than the choices available currently.

Global Orphan Diseases Testing Market: Key Segments

The global orphan diseases testing market can be segmented based on disease type, technology type, end-user, and region. Based on disease type, the Orphan Diseases Testing Market has been divided into cystic fibrosis, Lou Gehrig's disease, and Tourette's syndrome. Based on technology, the global orphan diseases testing market can be segmented into NGS platforms, RT-PCR, microarrays, and genetic analyzers. Next-generation sequencing is a DNA-sequencing technology, by which an entire human genome can be sequenced within a single day. Bioinformatics tools are used for analysis of the entire gene sequence for precise changes in a DNA sequence and hence, these tools are used in testing of orphan diseases. Based on end–user, the global orphan diseases testing market has been segmented into academic & research institutes, diagnostic centers, and others. Increasing R&D in the health care sector, which utilizes gene sequencing for the testing of orphan diseases, is expected to drive the orphan diseases testing market during the forecast period.

Based on region, the global orphan diseases testing market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global orphan diseases testing market in 2016. Dominance of the region is attributable to the presence of key players and rising research and development activities in the region. Rising awareness about orphan diseases and their testing in Asia Pacific is projected to fuel the orphan diseases testing market during the forecast period.

Global Orphan Diseases Testing Market: Key Players

Key players operating in the global orphan diseases testing market include Illumina, Inc., Thermo Fisher Scientific, Inc., and Bio-Rad Laboratories, Inc.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.

TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.

Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:

Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.

Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.

Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Orphan Diseases Testing Market

Pre Book